- All
- Product Management
- News and Information
- Introduction content
- Enterprise outlets
- Frequently Asked Questions
- Corporate Video
- Company Portfolio
Chemo Group founders attend the G20 Summit Forum
Release time:
2019-06-27 15:46
In 2016, the G20 Summit Agriculture Ministers Meeting was held today in Xi'an, Shaanxi Province.
The G20 Agricultural Entrepreneurs Forum, sponsored by this ministerial meeting, was held concurrently.

The forum invited well-known agricultural enterprises from G20 member countries and representatives from the UN Food and Agriculture Organization, the United Nations Conference on Trade and Development, the World Bank, the OECD and other international institutions of international finance, investment and consulting institutions. Mr. Hugo Sigman, founder of Chemo Group, attended the conference as a representative of the leading entrepreneurs in Latin America.

Mr. Sigman used the foot-and-mouth disease project jointly invested by China and Argentina (Argentina) as an example to illustrate the transformation and application of innovative biotechnology in agriculture and animal husbandry. Argentine Agriculture Minister Ricardo Buryayil pointed out that as a member of the G20, China and Afghanistan continue to promote bilateral cooperation agreements with Chinese companies and society. "Yangling Jinhai Biotechnology Co., Ltd." is a valuable sample of Sino-African cooperation.

The picture shows Hugo Sigman (third from left) and the Argentine Ministry of Agriculture official
“Yangling Jinhai Biotechnology Co., Ltd.” is the latest high-purity foot-and-mouth disease inactivated vaccine factory of international technology jointly established by Biogénesis Bagó Company in China and Shanghai Haili in Yangling, Shaanxi. This technology is produced by the current international advanced suspension culture and concentration purification technology. Highly purified foot-and-mouth disease inactivated vaccine. It is expected that the product will be available at the end of 2016. After the project is put into production, it will realize an annual production capacity of 400 million doses of foot-and-mouth disease vaccine, which will play a major role in the prevention of foot-and-mouth disease in China.
At the G20 Forum, Mr. Hugo Sigman shared the investment experience of this technology in China, which was the biggest highlight of the conference. It caused a lively response and was praised as the “world's strongest voice” of G20 agricultural enterprises.
inactivated vaccine